+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

TIL therapy - Pipeline Insight, 2024 - Product Thumbnail Image

TIL therapy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Metastatic colorectal cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic colorectal cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 250 Pages
  • Global
From
Chronic Myeloid Leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Myeloid Leukemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 230 Pages
  • Global
From
Marginal Zone Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Marginal Zone Lymphoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 150 Pages
  • Global
From
Malignant Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

Malignant Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Metastatic Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Uveal Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Uveal Melanoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 90 Pages
  • Global
From
Gastrointestinal Stromal Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

Gastrointestinal Stromal Tumors - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 85 Pages
  • Global
From
B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) Pipeline Insight, 2024 - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Adrenocortical Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Adrenocortical Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Adenoid Cystic Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Adenoid Cystic Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Clear Cell Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Clear Cell Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Post-Polycythemia Vera Myelofibrosis - Pipeline Insight, 2024 - Product Thumbnail Image

Post-Polycythemia Vera Myelofibrosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Thymic Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Thymic Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Cutaneous Squamous Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Cutaneous Squamous Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 120 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more